Fibrogenic signals persist in daa-treated hcv patients after sustained virological response

HIGHLIGHTS

• who: Claudia Montaldo from the University of Rome, Viale Regina Elena, Rome, ItalyTel have published the research work: Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response, in the Journal: (JOURNAL)
• what: The authors assess the impact of DAA therapy on liver fibrosis progression, analyzing the functional abilities and the Journal of Hepatology 2021 vol. As shown in Fig S4, this analysis provides functional evidence recapitulating the EV-based observation and enables identification of miRNAspecific targets . Structural analysis: circulating EV proteomic analysis Next, the authors aimed to characterize EV protein content; to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.